Quintiles, Inc. Announces Clinical Research Partnership with the University of Pretoria
Published: Sep 10, 2009
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced a strategic alliance agreement with the University of Pretoria as part of its industry unique Prime Site program, an initiative to accelerate the development of new and more effective medicines. The University of Pretoria is the third location in the Quintiles Prime Site program which already includes Queen Mary's College in London and the Washington Hospital Center in Washington DC.